Join us for a 30-minute introductory webinar on Diagnexia services in North America. Diagnexia is a Deciphex-powered pathology service that offers innovative diagnostic solutions to healthcare organizations worldwide.
Join our Chief Medical Officer, Prof. Runjan Chetty, and expert consultant pathologist for our Diagnexia service, Dr. Mahmut Akgul, for the second webinar in our "Challenging Cases" series.
The company has seen a 450% increase in demand for services since December. The expansion is expected to create numerous employment opportunities in the Exeter region, further stimulating the local economy.
Join our Chief Medical Officer, Prof. Runjan Chetty, and expert consultant pathologist for our Diagnexia service, Dr. Bayardo Perez-Ordonez, for the first webinar in our "Challenging Cases" series.
Our Chief Medical Officer, Prof. Runjan Chetty, spoke with Unity 101 radio station this week to discuss the role and importance of pathologists in the NHS
Diagnexia, a new generation of technology-enabled Pathology care provider, powered by Deciphex’s core technologies, and Saudi Ajal Medical Laboratories, a leader in the medical laboratory market of Saudi Arabia, today announced a strategic collaboration to offer secondary consultation pathology service in Saudi Arabia.
Diagnexia Announce their Appointment as a Supplier on The Countess of Chester Hospital National Framework Agreement for Teleradiology, Telepathology and Telemedicine Services.
Diagnexia is the first fully digital, subspecialty led, remote diagnostic & consult service.
Diagnexia is exhibiting at the Institute of Biomedical Science (IBMS) Congress 2022 in Birmingham, from the 14th - 17th of March.
Deciphex is exhibiting at Arab Health 2022 in Dubai, one of the world's leading healthcare and health technologies events.
Diagnexia, a new generation of technology-enabled care provider, powered by Deciphex’s core technologies, announces that they have secured CQC (Care Quality Commission) certification.